Author Archives 
Dr. Rocha is staff surgeon, surgical oncology and hepatopancreatobiliary surgery, and associate medical director, Floyd & Delores Jones Cancer Institute, Virginia Mason Medical Center; and clinical associate professor of surgery, University of Washington, Seattle.
Posts by Flavio G. Rocha, MD, FACS:
- Modified FOLFIRINOX is superior to gemcitabine as adjuvant therapy for resected pancreatic cancer: The PRODIGE 24/CCTG PA6 Trial
- Liquid biopsies in cancer clinical trials
- Adjuvant therapies for biliary tract cancers
- Studies address metabolic image-directed oncologic therapy for gastric cancer
- Less invasive option for small hepatocellular carcinoma: Thermal ablation as first-line therapy?
